Soligenix Inc. (SNGX)
Positive Clinical Results from HyBryte™Comparative Study EvaluatingHyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
Positive Clinical Results from HyBryte™Comparative Study EvaluatingHyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
📈 **POSITIVE** • Medium confidence analysis (69%) • Strong positive catalyst • High growth potential **Sentiment:** Positive (95%) **Content type:** General